Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation
Sigrun Einarsdottir(Memorial Sloan Kettering Cancer Center), Mats Brune(Sahlgrenska University Hospital), Mikael Olsson(Varberg Hospital), Björn Andréasson(NU Hospital Group), Tomas Bergström(Sahlgrenska University Hospital), Bénédicte Piauger(University of Gothenburg), Malin Nicklasson(University of Gothenburg), Malin Veje(Sahlgrenska University Hospital), Per Ljungman(Karolinska University Hospital), Berit Johansson(Södra Älvsborg Hospital), Marie Studahl(Sahlgrenska University Hospital), Mikael Lisak(University of Gothenburg), Anette Roth(University of Gothenburg), Vanda Friman(University of Gothenburg)
Cited by 8
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
|Bone Marrow Transplantation|2009|385